Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof
US12281148B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2024 |
| Grant date | Apr 22, 2025 |
| Priority date | — |
| Expiry date | Sep 3, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed herein are modified human interleukin-2 (hIL-2) proteins, human antibody molecules, or antigen-binding fragments thereof, that immunospecifically bind to human programmed cell death protein-1 (hPD-1), and immunoconjugates comprising the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.